Fierce Pharma
JANUARY 30, 2024
After 'bad launch' remark by CEO, Pfizer's RSV vaccine gains traction in Q4. How will it fare in latest round of GSK showdown?
Dominic Tyer
JANUARY 30, 2024
Successful customer engagement will require pharma companies to maintain a rigid focus throughout the journey
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JANUARY 30, 2024
2seventy Bio has traveled a difficult path ever since it spun out from bluebird bio to work on cancer cell therapies. | 2seventy Bio has traveled a difficult path ever since it spun out from bluebird bio to work on cancer cell therapies. Now, the company is splitting in two once again, passing its R&D programs to Regeneron and going all-in on its Bristol Myers Squibb-partnered CAR-T Abecma.
MedCity News
JANUARY 30, 2024
Even just a year ago, we couldn’t fathom a cure for cancer. Now, we can. Artificial intelligence (AI) is rapidly transforming the healthcare industry, with its ability to process and analyze vast amounts of data. Cancer treatment is one area that could benefit significantly from AI, as it can aid in early detection, precise diagnosis, and personalized treatment plans.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Fierce Pharma
JANUARY 30, 2024
A nasal gel version of the motion sickness drug scopolamine has failed to make the grade with the FDA. The U.S. | A nasal gel version of the motion sickness drug scopolamine has failed to make the grade with the FDA. The U.S. regulator has sent a complete response letter to Defender Pharmaceuticals, rejecting DPI-396 for the prevention of nausea and vomiting induced by motion.
MedCity News
JANUARY 30, 2024
A preview of ViVE 2024 offers a sneak peek at the agenda and how the Payer and Provider Connect meeting platform initiatives have been revamped to maximize the quantity and quality of meeting for healthcare executives.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JANUARY 30, 2024
Regeneron Pharmaceuticals is paying $5 million up front for 2seventy bio’s cancer drug pipeline. 2seventy will now focus on a cell therapy commercialized with partner Bristol Myers Squibb while Regeneron adds assets for its newly formed cell therapy division.
pharmaphorum
JANUARY 30, 2024
Elon Musk’s Neuralink company has said it has implanted its wireless brain implant device into a human being for the first time
MedCity News
JANUARY 30, 2024
Chronic pain, an enduring concern for many older adults, is no longer confined to the traditional realm of pharmaceuticals. While traditional pain management methods like medication were once the go-to approach, alternative therapies are emerging as a viable and holistic approach to addressing this issue.
pharmaphorum
JANUARY 30, 2024
From today, a new feature added to the NHS App used in the UK will allow millions of people to submit and view prescriptions, in a bid to save time for patients and doctors. The digital prescription function, which does away with the need for paper scrip, was put through its paces in a pilot trial last year involving a million users of the app, now being used by three-quarters of the UK population or around 33.5 million people.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
MedCity News
JANUARY 30, 2024
As key opinion leaders (KOLs), nurses can provide insights on unmet clinical needs, identify gaps in treatment options, and contribute to the development of better and more patient-centric solutions. Here are three core reasons why pharmaceutical companies should tap the power of nurses.
PharmaTimes
JANUARY 30, 2024
Type 2 diabetes is estimated to affect 462 million people worldwide
pharmaphorum
JANUARY 30, 2024
Legislation filed in the US is seeking to block Chinese biotech companies from federal contracts on the grounds they are a national security concern
MedCity News
JANUARY 30, 2024
Anne Osdoit, CEO of Moon Surgical, explains how the Maestro System may be expanding the surgical robotics pie by bringing the capability to newer markets and how surgical robotics do not have to break the bank.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Technology
JANUARY 30, 2024
The EMA has accepted GSK’s regulatory application seeking expansion of its RSVvaccine, Arexvy, to include adults aged 50 to 59 years.
MedCity News
JANUARY 30, 2024
For the first episode of 2024, Senior Reporter Katie Adams discussed some executive hires, promotions and departures that recently took place in the healthcare world, as well as layoffs affecting the industry. We also hear from Kristin Myers, who recently became Northwell Health’s first chief digital officer.
pharmaphorum
JANUARY 30, 2024
Vertex Pharma says its much-anticipated non-opioid painkiller, VX-548, clears two phase 3 trials en route to an FDA filing later this year
MedCity News
JANUARY 30, 2024
Blue Shield of California Promise Health Plan is working with the GED Testing Service to help members earn a General Educational Development (GED) diploma for no cost. Members can register online and gain access to GED study materials in both English and Spanish.
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
European Pharmaceutical Review
JANUARY 30, 2024
The European Medicine Agency’s human medicines committee (CHMP) recommended marketing authorisations for the regulatory approval of three medicines at its January 2024 meeting last week. The CHMP recommended Exblifep (cefepime/enmetazobactam) as a treatment for complicated urinary tract infections, including pyelonephritis, hospital-acquired pneumonia, including ventilator associated pneumonia, and for treating bacteraemia caused by the aforementioned infections.
MedCity News
JANUARY 30, 2024
Proven to offer cost-effective solutions, Real-Time Location Systems (RTLS) can ease operational burdens for efficiency and enhance the relationship between patients and caregivers, enabling a more human-focused experience for all.
European Pharmaceutical Review
JANUARY 30, 2024
Results from a Phase III, randomised, placebo-controlled clinical trial have for the first time in fifty years, demonstrated an overall survival benefit from an adjuvant therapy in kidney cancer. Pembrolizumab targets a “checkpoint” pathway that is key in enabling cancer cells to avoid being destroyed by the immune system. As a result, the immunotherapy drug supports the immune system’s T cells fight tumours, the researchers highlighted.
MedCity News
JANUARY 30, 2024
Valendo Health, the newest startup built at Redesign Health, launched on Tuesday. The startup partners with independent endocrinology practices and provides technology to help them thrive in value-based care arrangements.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmaceutical Technology
JANUARY 30, 2024
Vertex is planning to submit a new drug application to the FDA following the announcement of its Phase III programme meeting its primary endpoint.
PharmaTimes
JANUARY 30, 2024
Around one million adults in the UK visit their GP every year due to chest pain
PharmaVoice
JANUARY 30, 2024
Barinthus Biotherapeutics wants to be known for more than its pandemic ties, CEO Bill Enright said.
Pharmaceutical Technology
JANUARY 30, 2024
The funds secured by France-based biotech Aqemia, which partnered with Sanofi late last year, bring its Series A funding sum to $65m.
Advertiser: ZoomInfo
As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.
PharmaVoice
JANUARY 30, 2024
Despite a recent safety warning from the FDA, companies such as BMS and J&J stress that the benefits of their cancer therapies still outweigh the risks.
Pharmacy Times
JANUARY 30, 2024
Investigators determined the effectiveness of behavioral activation psychotherapy versus antidepressant medication management for inpatients with heart failure and depression.
PharmaTech
JANUARY 30, 2024
Various impurities can infiltrate the container closure system in pharmaceutical manufacturing. Understanding nitrosamines, elemental impurities, extractables, and leachables can help ensure the safety of the final product.
Pharmacy Times
JANUARY 30, 2024
Inadequate levels of zinc, vitamin D, vitamin E, and vitamin B were also associated with risk of diabetes or diabetes-related complications.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Expert insights. Personalized for you.
264 
Let's personalize your content